ACTRN12605000739617
Recruiting
未知
Microvascular complications in patients with Type 1 Diabetes. To determine the relationship between abnormalities of autonomic function and markers of microvascular disease and cardiovascular risk in patients with Type 1 Diabetes.
Sydney Diabetes Clinical Research Unit, Royal North Shore Hospital0 sites50 target enrollmentNovember 11, 2005
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Type 1 diabetes mellitus
- Sponsor
- Sydney Diabetes Clinical Research Unit, Royal North Shore Hospital
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients who have been informed of the study procedure and have given written informed consent.2\. Unequivocal diagnosis of Type 1 diabetes mellitus.
Exclusion Criteria
- •1\. Patients who are unwilling or unable to attend the clinic on two consecutive days.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Comparative study of vascular complications related to arterial sheet extraction using clamp ease device and hand pressure in patients undergoing angiography.This study is performed in the field of vascular injuries after the invasive action of arterial sheet removal.cardiovascular disease NOSI51.6IRCT20211121053121N2Isfahan University of Medical Sciences94
Not yet recruiting
Not Applicable
Innate immunity and vascular complications in type II diabetic South-Asian immigrantscardiovascular diseasediabetesnephropathyretinopathy100110821004706010029149NL-OMON30311Academisch Medisch Centrum169
Recruiting
Not Applicable
Comparison of vascular complications in carotid artery stenting with and without the use of embolic protection deviceCarotid Stenosis.Occlusion and stenosis of carotid arteryI65.2IRCT20140712018457N7Tehran University of Medical Sciences60
Recruiting
Not Applicable
Post-operative exercise training for peripheral arterial diseaseACTRN12616001232426niversity of the Sunshine Coast30
Active, not recruiting
Phase 1
FAME 1 Eye trialTo evaluate the effects of once daily oral fenofibrate compared with placebo on clinically meaningful retinopathy progression over at least 3 years in adults with Type 1 diabetes (T1D) and existing diabetic retinopathyMedDRA version: 21.1Level: LLTClassification code 10012608Term: Diabetes mellitus insulin-dependentSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2019-002591-14-GBBelfast Health & Social Care Trust450